percentage of us population on glp 1 The GLP-1 Capitals: Where Weight Loss Injections Are Taking Over How Many Americans Are on

Research shows that these medications can lower the risk of major cardiac-related events, including heart attack and stroke, especially in those with type 2 diabetes or existing heart disease, says Brynna Connor, MD, ABFM, a diplomate of the American Academy of Anti-Aging/Regenerative Medicine

Seeley, Darleen Sandoval, Martin G

Effects of Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide on Cardiovascular and Renal Outcomes Across Body Mass Index Categories in Type 2 Diabetes: Results of the LEADER and SUSTAIN 6 Trials

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society, Obesity Pillars